We are live on ! Find out more
MTCR

Metacrine, Inc. Common Stock
MTCR

Delisted

MTCR was delisted on the 8th of February, 2023.

Back to rankings

47 hedge funds and large institutions have $82.1M invested in Metacrine, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

12% more funds holding

Funds holding: 42 → 47 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

22% less capital invested

Capital invested by funds: $105M → $82.1M (-$22.5M)

Holders
47
Holders Change
+5
Holders Change %
+11.9%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
12
Reduced
15
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$2.13M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.3M
3
BCM
Bridgeway Capital Management
Texas
+$1.19M
4
PPA
Parametric Portfolio Associates
Washington
+$465K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$423K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$2.4M
2
PM
Prosight Management
Texas
-$2.29M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.66M
4
Millennium Management
Millennium Management
New York
-$366K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$254K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$95K +$136K +15,356 New
Charles Schwab
27
Charles Schwab
California
$86K – – –
M&T Bank
28
M&T Bank
New York
$82K +$13.9K +1,572 +13%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$69K +$98.2K +11,090 New
Two Sigma Advisers
30
Two Sigma Advisers
New York
$68K -$52.3K -5,900 -35%
N
31
Nuveen
North Carolina
$68K – – –
Goldman Sachs
32
Goldman Sachs
New York
$66K -$74.7K -8,431 -44%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$62K – – –
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$44K – – –
Morgan Stanley
35
Morgan Stanley
New York
$36K -$28.7K -3,244 -36%
Deutsche Bank
36
Deutsche Bank
Germany
$26K -$3.51K -396 -9%
UBS Group
37
UBS Group
Switzerland
$15K +$7.93K +895 +60%
Wells Fargo
38
Wells Fargo
California
$13K -$12.3K -1,393 -40%
SO
39
STRS Ohio
Ohio
$9K – – –
TRCT
40
Tower Research Capital (TRC)
New York
$8K -$10.5K -1,181 -48%
Citigroup
41
Citigroup
New York
$3K -$5.52K -623 -54%
AIP
42
Ameritas Investment Partners
Nebraska
$3K – – –
Legal & General Group
43
Legal & General Group
United Kingdom
$3K – – –
EWM
44
Edge Wealth Management
New York
$2K +$2.66K +300 New
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$1K -$7.37K -832 -78%
AIG
46
American International Group
New York
$24 +$89 +10 +0.3%
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
– -$254K -32,253 Closed
Osaic Holdings
48
Osaic Holdings
Arizona
– +$133 +15 New
1
2

MTCR Hedge Fund Activity: Q1 2021 in Review

47 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Metacrine, Inc. Common Stock (MTCR) for Q1 2021, worth a combined $82.1M — down 22% from $105M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MTCR positions and 1 closed out — a net gain of 5 holders — while 12 added to existing stakes and 15 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $2.13M. The largest seller was EcoR1 Capital, cutting an estimated $2.4M.

  • 47 institutional investors held Metacrine, Inc. Common Stock (MTCR) as of Q1 2021, up from 42 in Q4 2020.
  • Funds reported $82.1M of Metacrine, Inc. Common Stock stock for Q1 2021, down 22% quarter-over-quarter.
  • 6 funds opened new Metacrine, Inc. Common Stock positions in Q1 2021 and 1 closed out, a net change of +5 holders.
  • The largest Metacrine, Inc. Common Stock buyer in Q1 2021 was JP Morgan Chase, an estimated $2.13M added.
  • The largest Metacrine, Inc. Common Stock seller in Q1 2021 was EcoR1 Capital, an estimated $2.4M sold.

Based on aggregated 13F filings for Q1 2021.